Soluble immune checkpoints reflect immune activation and treatment response in high-risk systemic sclerosis patients treated with plasma exchange.

Saved in:
Bibliographic Details
Title: Soluble immune checkpoints reflect immune activation and treatment response in high-risk systemic sclerosis patients treated with plasma exchange.
Authors: Potjewijd J; Department of Internal Medicine, Division Clinical and Experimental Immunology, Maastricht University Medical Center, Maastricht, the Netherlands., Tobal R; Department of Internal Medicine, Division Clinical and Experimental Immunology, Maastricht University Medical Center, Maastricht, the Netherlands., van Doorn DPC; Department of Internal Medicine, Division Clinical and Experimental Immunology, Maastricht University Medical Center, Maastricht, the Netherlands., Schurgers LJ; Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, the Netherlands., Heeringa P; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Damoiseaux JGMC; Central Diagnostic Laboratory, Maastricht University Medical Center, Maastricht, the Netherlands., van Paassen P; Department of Internal Medicine, Division Clinical and Experimental Immunology, Maastricht University Medical Center, Maastricht, the Netherlands.
Source: Journal of translational autoimmunity [J Transl Autoimmun] 2026 Feb 19; Vol. 12, pp. 100361. Date of Electronic Publication: 2026 Feb 19 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101759413 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-9090 (Electronic) Linking ISSN: 25899090 NLM ISO Abbreviation: J Transl Autoimmun Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2589-9090
DOI:10.1016/j.jtauto.2026.100361